Mucosal Vaccines, Adjuvants & Delivery

25-27 September 2013, Eigtveds Pakhus, Copenhagen, Denmark

  • Increase font size
  • Default font size
  • Decrease font size

Poster Session

Poster 101
‘Immunogenicity of a DNA vaccine candidate in mice is predetermined by the efficacy of intradermal gene electrotransfer’
Stefan Petkov et al. (Karolinska Institutet, Stockholm, Sweden)

Poster 102
‘cAMP-activating adjuvants (LT, mLT-R192G, dmLT-R192G/L211A) stimulate Th17 responses through dendritic cells, while direct CD4 T-cell contact produces a T-suppressor phenotype’
Elizabeth B. Norton et al. (Tulane University School of Medicine, New Orleans, Louisiana, USA)

Poster 103
‘Characterisation and functional specificity of mucosal DC subsets in response to TLR ligands’
Stephanie L. Sanos et al. (Bavarian Nordic GmbH, Martinsreid, Germany)

Poster 104
‘Evaluation of the mucosal adjuvant Endocine™: Longevity study of humoral immune response and comparison with adjuvants Cholera toxin and Alum’
Tina Falkeborn et al. (Eurocine Vaccines AB, Solna, Sweden)

Poster 105
‘Immunose™ FLU a nasal influenza vaccine conferring complete protection in influenza naive ferrets’
Anna-Karin Maltais et al. (Eurocine Vaccines AB, Solna, Sweden)

Poster 106
‘pH-sensitive coating of silicon microneedle arrays for pH triggered dermal protein delivery’
Romain Leboux et al. (Leiden University, Leiden, The Netherlands)

Poster 107
‘Am80 formulated in cationic liposomes acts as a cofactor to promote mucosal IgA secretion in mice after parenteral immunization’
Pascal Chaux et al. (Sanofi Pasteur, Marcy l’Etoile, France)

Poster 108
‘Swine plasma immunoglobulins for prevention and treatment of post-weaning diarrhea: Optimizing stability towards gut conditions’
Chris Juul Hedegaard et al. (Technical University of Denmark, Frederiksberg, Denmark)

Poster 109
‘Nanoparticle conjugation and pulmonary administration of a multistage tuberculosis vaccine candidate’
Daniel Bonner et al. (EPFL, Lausanne, Switzerland)

Poster 110
‘A potent cytotoxic T cell epitope in the extracellular domain of influenza B virus NB promotes virus clearance’
Kenny Roose et al. (University of Ghent, Ghent, Belgium)

Poster 111
‘Yeast particles targeted to aminopeptidase N as antigen delivery system to porcine immune cells’
Kim Baert et al. (University of Ghent, Ghent, Belgium)

Poster 112
‘Lipopeptide structure-activity relationship for the development of a self-adjuvanting, mucosally active group A streptococcus (GAS) vaccine candidate’
Mehfuz Zaman et al. (The University of Queensland, Brisbane, Queensland, Australia)

Poster 113
‘The expression of M2e peptide of avian influenza virus H5N1 in translational fusion with subunit B of ricin in the transgenic tobacco and duckweed plants’
A.P. Firsov et al. (Russian Academy of Sciences, Pushchino, Moscow Region, Russia)

 

MUCOVAD 2013 Delegates

Login details will be supplied after you have registered for the event.


MUCOVAD 2013 Sponsors

  • Izon
  • Pevion Vaccines
  • Current Drug Delivery
  • Univac
  • Mucosis
  • Immune Solutions
  • Inovio Pharmaceuticals
  • Eurocine Vaccines
  • PATH
  • Nature Gene Therapy
  • DNA Vaccine
  • Retroscreen Virology
  • Aldevron
  • Drug Delivery Letters
  • Biovaxx
  • Sanofi Pasteur

MUCOVAD 2013 Downloads

MUCOVAD 2013 Leaflet

MUCOVAD 2013 Mailing List

Name
E-mail Address
What is 1+4-2?